Indo Rama Synthetics (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
INDORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Indo Rama Synthetics approved audited standalone and consolidated financial results for Q4 and FY25 on May 13, 2025, with auditor Walker Chandiok & Co LLP issuing an unmodified opinion. Standalone revenue from operations rose to Rs. 5,622.65 crore (vs Rs. 5,291.55 crore in FY24, ~6% growth), and the company swung back to a profit after tax of Rs. 15.6 crore from a loss of Rs. 110.4 crore in FY24. Consolidated revenue grew to Rs. 5,928.16 crore with a marginal consolidated profit after tax of Rs. 1.3 crore versus a loss of Rs. 158.5 crore last year. Operating cash flow turned sharply positive at Rs. 335.86 crore (standalone) and Rs. 391.11 crore (consolidated), compared with heavy outflows in FY24. Total equity improved to Rs. 452.96 crore (standalone) on the back of the profit turnaround, and current borrowings were reduced from Rs. 904.40 crore to Rs. 689.84 crore.
This is a clear turnaround story — the company moved from a loss to a profit, generated strong operating cash flow, and deleveraged short-term debt, which is positive for shareholders. However, current liabilities exceed current assets by Rs. 612.49 crore (standalone) and the auditor flagged an Emphasis of Matter on recoverability of Rs. 258.61 crore in deferred tax assets, so investors should monitor liquidity and future earnings delivery closely.